These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34417704)

  • 1. Neurological manifestations of COVID-19 in patients: from path physiology to therapy.
    Merino JJ; Macho-González A; Benedi J; González MP
    Neurol Sci; 2021 Dec; 42(12):4867-4879. PubMed ID: 34417704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
    Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
    Front Immunol; 2021; 12():674922. PubMed ID: 34040615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological Involvements of SARS-CoV2 Infection.
    Gasmi A; Tippairote T; Mujawdiya PK; Gasmi Benahmed A; Menzel A; Dadar M; Bjørklund G
    Mol Neurobiol; 2021 Mar; 58(3):944-949. PubMed ID: 33064267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review.
    Ramachandran AK; Das S; Joseph A
    Curr Neuropharmacol; 2021; 19(10):1688-1700. PubMed ID: 33441073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimmune disorders in COVID-19.
    Ariño H; Heartshorne R; Michael BD; Nicholson TR; Vincent A; Pollak TA; Vogrig A
    J Neurol; 2022 Jun; 269(6):2827-2839. PubMed ID: 35353232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urodynamic AUR in Guillain-Barré syndrome post-infection by coronavirus Sars-CoV-2. A bibliographic review.].
    Méndez-Rubio S; Laso-Martín S; Jerez-Izquierdo T; Lorenzo-García C; López-Pérez E; Vives-Dilme R; Fernández-Hernández L; Méndez-Cea B; Moreno-Sierra J; Virseda-Chamorro M; Salinas-Casado J
    Arch Esp Urol; 2022 Jan; 75(1):7-18. PubMed ID: 35173070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Nervous System Manifestations Associated with COVID-19.
    Andalib S; Biller J; Di Napoli M; Moghimi N; McCullough LD; Rubinos CA; O'Hana Nobleza C; Azarpazhooh MR; Catanese L; Elicer I; Jafari M; Liberati F; Camejo C; Torbey M; Divani AA
    Curr Neurol Neurosci Rep; 2021 Feb; 21(3):9. PubMed ID: 33586020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome with bilateral facial diplegia secondary to severe acute respiratory syndrome coronavirus-2 infection: a case report.
    Ramirez N; Ujueta D; Diaz LF; Folleco LE; Rodríguez A; Gaona I; Nava-Mesa MO
    J Med Case Rep; 2021 Nov; 15(1):558. PubMed ID: 34782002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bifacial weakness with paresthesia – a rare Guillain–Barré syndrome subtype associated with SARS-CoV-2 infection].
    Gaál T; Szeszák G; Torák G; Salacz P
    Orv Hetil; 2021 Nov; 162(45):1803-1807. PubMed ID: 34747359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms.
    Mohammadi S; Moosaie F; Aarabi MH
    Mol Neurobiol; 2020 Dec; 57(12):5263-5275. PubMed ID: 32869183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
    Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
    J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological symptoms as a clinical manifestation of coronavirus disease 2019: implications for internists.
    Adamczyk-Sowa M; Niedziela N; Kubicka-Bączyk K; Wierzbicki K; Jaroszewicz J; Sowa P
    Pol Arch Intern Med; 2021 Jan; 131(1):54-62. PubMed ID: 32820884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barré syndrome.
    Galassi G; Marchioni A
    Acta Neurol Belg; 2020 Oct; 120(5):1067-1075. PubMed ID: 32696312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms.
    Johansson A; Mohamed MS; Moulin TC; Schiöth HB
    J Neuroimmunol; 2021 Sep; 358():577658. PubMed ID: 34304141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurologic aspects of covid-19: a concise review.
    Brouwer MC; Ascione T; Pagliano P
    Infez Med; 2020 Jun; 28(suppl 1):42-45. PubMed ID: 32532937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
    Khalifa M; Zakaria F; Ragab Y; Saad A; Bamaga A; Emad Y; Rasker JJ
    J Pediatric Infect Dis Soc; 2020 Sep; 9(4):510-513. PubMed ID: 32652520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Direct and indirect neurological manifestations of COVID-19].
    Gromova OA; Torshin IY; Semenov VA; Putilina MV; Chuchalin AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(11):11-21. PubMed ID: 33340292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.